Biotechnology
Avance Clinical To Showcase New Early Phase Center Of Excellence At Biotech Showcase 2026
Share
ADELAIDE, Australia, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Avance Clinical, the award-winning Australian led, global CRO built exclusively to service the clinical research needs of biotech companies, announced today that its executive team will attend Biotech Showcase 2026 in San Francisco, January 12-14, to meet with innovative biotech sponsors and highlight the company’s newly launched Early Phase Center of Excellence for Biotechs.
Designed specifically for emerging biotechs, the Early Phase Center of Excellence brings together Avance Clinical’s scientific, regulatory, and operational experts to streamline first-in-human and proof-of-concept development. The Center of Excellence provides sponsors with enhanced support across protocol design, site selection, regulatory strategy, operational efficiency and translational data integration to accelerate decision-making and program development timelines.
Avance Clinical CEO Mark Harvill emphasized the importance of this milestone:
“Biotech innovators need partners who can deliver speed, quality, and strategic insight from the very start. Our Early Phase Center of Excellence is built to meet that need - combining our world-class operational capabilities with the advantages of running early-phase research. We’re excited to meet with sponsors at Biotech Showcase to show how we can help them reach critical early milestones faster, more efficiently, and with global regulatory confidence,” he said.
The Australian Advantage: A Development Pathway Designed for Biotechs
A key differentiator in Avance Clinical’s model is leveraging the Australian Advantage, including:
- No IND required to begin many early-phase clinical trials, enabling startup in as little as 5–6 weeks.
- Qualified and highly experienced Phase I units and bioanalytical laboratories with strong capabilities.
- Globally accepted data suitable for FDA and EMA submissions.
- Maximize Australia’s R&D tax incentive, up to 43.5% and favorable exchange rate, significantly reducing early clinical development costs.
Early Phase Optionality
Avance Clinical is also conducting early phase trials in the USA and UK in partnership with globally recognised Phase I facilities. This offers our clients unrivalled optionality to a global platform to accelerate their early phase clinical development program.
These benefits, paired with Avance Clinical’s seamless transition pathways into global Phase II studies, provide biotechs with a uniquely accelerated and cost-efficient development model.
A Strong Presence at Biotech Showcase 2026
During the conference, Avance Clinical will meet with biotechs seeking a partner capable of delivering rapid early-phase execution, robust scientific support, and global trial continuity. The team will share insights into its Rapid Startup Framework, global expansion capabilities, and how the Early Phase Center of Excellence is purpose-built to help sponsors deliver high-quality data earlier in development.
Ben Edwards, Chief Operating Officer at Avance Clinical said, “Biotech Showcase is one of the year’s most important gatherings for early-stage innovators, and we look forward to connecting with companies ready to move quickly and strategically. Avance Clinical has always been committed to helping biotech's succeed - and our new Center of Excellence strengthens that commitment to a new level.”
About Avance Clinical
Avance Clinical is the largest premium full-service Australian headquartered CRO delivering high-quality clinical trials in Australia, New Zealand, Asia and North America for biotechs. The company has won multiple Frost & Sulivan CRO Market Leadership and Customer Value Leadership Awards. With over 30 years of experience and deep expertise across more than 250 indications, Avance Clinical provides services from pre-clinical consulting to late phase trials, supported by best-in-class regulatory, clinical and operational expertise.
Find out more:
- Visit our website to find out more or request a proposal www.avancecro.com
- Find out more about the Early Phase Center of Excellence
- Book a Meeting with our expert team
- Meet Avance Clinical at upcoming conferences
CONTACT
Frequently Asked Questions
What is Avance Clinical's new Early Phase Center of Excellence?
It's a specialized center designed for emerging biotechs, bringing together scientific, regulatory, and operational experts to streamline first-in-human and proof-of-concept development, enhancing support across various aspects of clinical trials.
What are the key advantages of Avance Clinical's Australian model?
The Australian Advantage includes no IND requirement for many early-phase trials (allowing startup in 5-6 weeks), globally accepted data for FDA and EMA submissions, and an R&D tax incentive of up to 43.5%.
Where can Avance Clinical's executive team be met to discuss their services?
The executive team will attend Biotech Showcase 2026 in San Francisco, from January 12-14, to meet with biotech sponsors and highlight their new Early Phase Center of Excellence.
First published on Mon, Jan 12, 2026
Enjoyed what you've read so far? Great news - there's more to explore!
Stay up to date with the latest news, a vast collection of tech articles including introductory guides, product reviews, trends and more, thought-provoking interviews, hottest AI blogs and entertaining tech memes.
Plus, get access to branded insights such as informative white papers, intriguing case studies, in-depth reports, enlightening videos and exciting events and webinars from industry-leading global brands.
Dive into TechDogs' treasure trove today and Know Your World of technology!
Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs' members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs' Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. While we aim to provide valuable and helpful information, some content on TechDogs' site may not have been thoroughly reviewed for every detail or aspect. We encourage users to verify any information independently where necessary.
Trending GlobeNewswire
Loyaltylion Launches AI Campaigns To Help Shopify Brands Drive More Loyalty Revenue
Overworld Unveils Real-Time Diffusion World Model For Playable, AI-Native Worlds
Intuitive.Ai Partners With Matilda Cloud To Accelerate Secure, Compliant AI And Cloud Modernization For Life Sciences
AI-First Hits Amazon Best Sellers List: The Executive Blueprint For Transformation
Activengage To Unveil AI Suite Of Products At NADA Show 2026
Join Our Newsletter
Get weekly news, engaging articles, and career tips-all free!
By subscribing to our newsletter, you're cool with our terms and conditions and agree to our Privacy Policy.
Join The Discussion